These findings provide clinical relevance to mechanisms that drive asthma pathology such as the synergistic effects of TLR4 signaling and the degradation of epithelial junctional proteins that can lead to increased epithelial barrier disruption, facilitating allergen penetration and triggering downstream inflammatory responses. This evidence concerns the gene TLR4 and asthma.